Israel’s Teva gets FDA nod for treating schizophrenia in adult patients
HQ Team October 10, 2026: Israel’s Teva Pharmaceutical Industries Ltd’s, Weltruza, a once-monthly injection for treatment of schizophrenia in adults, has been approved
HQ Team October 10, 2026: Israel’s Teva Pharmaceutical Industries Ltd’s, Weltruza, a once-monthly injection for treatment of schizophrenia in adults, has been approved
The US Food and Drug Administration has approved Asahi Kasei Therapeutics, Inc’s oral drug to treat mucocutaneous lesions caused by herpes simplex virus
GSK Plc will invest $800 million in Montgomery, Pennsylvania to build a biopharmaceutical innovation and manufacturing hub, according to the state governor Josh
The East African nation of Kenya confirmed its first case of Ebola after one of its citizens who flew into the capital, Nairobi,
New York Governor Kathy Hochul declared a state of emergency in the most populous city in the United States over a measles outbreak.
HQ Team October 5, 2026: Non-communicable diseases (NCDs) accounted for eight of the world’s ten leading causes of death in 2023, up from
HQ Team October 4, 2026: China’s Abogen Biosciences has signed a $7.8 billion licensing and option pact with Novartis AG to make messenger
HQ Team September 24, 2026: Osteoporosis, a disease that thins bones and makes patients vulnerable to fractures at the slightest falls. This progressive
HQ Team September 23, 2026: The human brain didn’t evolve as one single unit, but as two distinct organs independently, Stanford researchers found
HQ Team September 23, 2026: Novo Nordisk A/S or Novo, has partnered with UNICEF to expand their global partnership for four years to